Discriminative and predictive properties of disease-specific and generic health status indexes in elderly COPD patients by Conte, Maria E et al.
BioMed  Central
Page 1 of 7
(page number not for citation purposes)
BMC Pulmonary Medicine
Open Access Research article
Discriminative and predictive properties of disease-specific and 
generic health status indexes in elderly COPD patients
Maria E Conte1, Claudio Pedone*1, Francesco Forastiere2, Vincenzo Bellia3 
and Raffaele Antonelli-Incalzi1,4
Address: 1Area di Geriatria, Università Campus Biomedico, Roma, Italy, 2Dipartimento di Epidemiologia, ASL Roma E, Roma, Italy, 3Dipartimento 
di Medicina, Pneumologia, Fisiologia e Nutrizione Umana (DIMPEFINU), Università di Palermo, Palermo, Italy and 4Fondazione S. Raffaele – 
Cittadella Della Carità, Taranto, Italy
Email: Maria E Conte - m.conte@unicampus.it; Claudio Pedone* - c.pedone@unicampus.it; Francesco Forastiere - forastiere@asplazio.it; 
Vincenzo Bellia - vbellia@unipa.it; Raffaele Antonelli-Incalzi - r.antonelli@unicampus.it
* Corresponding author    
Abstract
Background: The association between bronchial obstruction severity and mortality in Chronic
Obstructive Pulmonary Disease (COPD) is well established, but it is unknown whether disease-
specific health status measures and multidimensional assessment (MDA) have comparable
prognostic value.
Methods: We analyzed data coming from the Salute Respiratoria nell'Anziano (Respiratory Health
in the Elderly – SaRA) study, enrolling elderly people attending outpatient clinics for respiratory
and non-respiratory problems. From this population we selected 449 patients with bronchial
obstruction (77.3% men, mean age 73.1). We classified patients' health status using tertiles of the
Saint George Respiratory Questionnaire (SGRQ) and a MDA including functional (the 6' walking
test, WT), cognitive (Mini-Mental State Examination, MMSE) and affective status (Geriatric
Depression Scale, GDS). The agreement of the classification methods was calculated using the
kappa statistic, and survival associated with group membership was evaluated using survival analysis.
Results: Pulmonary function, expressed by the FEV1, worsened with increasing SGRQ or MDA
scores. Cognitive function was not associated with the SGRQ, while physical performance and
mood status were impaired only in the highest tertile of SGRQ. A poor agreement was found
between the two classification systems tested (k = 0.194). Compared to people in the first tertile
of SGRQ score, those in the second tertile had a sex-adjusted HR of 1.22 (0.75 – 1.98) and those
in the third tertile of 2.90 (1.92 – 4.40). The corresponding figures of the MDA were 1.49 (95% CI
1.02 – 2.18) and 2.01 (95% CI: 1.31 – 3.08). After adjustment for severity of obstruction, only a
SGRQ in the upper tertile was associated with mortality (HR: 1.86; 95% CI: 1.14 – 3.02).
Conclusion: In elderly outpatients with mild-moderate COPD, a disease-specific health status
index seems to be a better predictor of death compared to a MDA.
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Background
The rapid increase of COPD prevalence has important
implications for health care and costs [1,2], although
most of these effects are attributable to comorbid diseases
[3,4]. Given that the mean age of COPD patients is con-
tinuously rising [5] and older age is associated with
comorbidity [6], we expect that comorbidity will more
and more contribute to shape the health status profile and
to affect the prognosis of COPD patients. As a conse-
quence, instruments rating disease-specific health status
might lose part of their prognostic value because they
have been developed in adult COPD populations free
from or with minor comorbidity [3,7]. On the other hand,
simple indicators of performance in physical and cogni-
tive domains may predict survival of COPD patients
because they are effective in broad elderly populations
with multiple chronic diseases [8,9]. For instance, both
cognitive impairment and poor physical performance
have been associated with worse survival in patients with
chronic heart failure [10,11]. Furthermore, being applica-
ble in different populations, performance indexes can
provide information on prognosis independently of the
main diagnosis, allowing to compare prognosis of
patients with different underlying disease.
To date, only a few study are available on the prognostic
significance of disease-specific health status indexes such
as the St. George Respiratory Questionnaire [12-15], and,
to our knowledge, no study has insofar investigated the
prognostic value of a multidimensional assessment
(MDA), i. e. of an objective rating of different dimensions
of health status, in the COPD population. Therefore, we
compared a generic MDA and a disease-specific health sta-
tus measure to evaluate their capacity to provide prognos-
tic information in elderly patients with COPD.
Methods
Data source
We used data coming from the Salute Respiratoria
nell'Anziano (Respiratory Health in the Elderly, SaRA)
study. Between January 1996 and July 1999 a total of
1970 outpatients were recruited from 24 departments of
geriatrics or respiratory medicine within the context of the
SaRA (Salute Respiratoria nell'Anziano – Respiratory
Health in the Elderly) study. Details on the SaRA project
are available elsewhere [16]. This is a multi-centre Italian
project, investigating various aspects of chronic airway
diseases in the elderly population (age ≥ 65 years) attend-
ing pulmonary or geriatric outpatient clinics for respira-
tory and non-respiratory problems. Data from individual
centres were collected by a coordinating centre at the Cat-
tedra di Malattie dell'Apparato Respiratorio of the Univer-
sity of Palermo, which was also responsible for the quality
control, the retrieval and the final processing of data.
All the patients underwent health status assessment by the
disease-specific Saint George Respiratory Questionnaire
(SGRQ) [17] and a geriatric MDA covering several areas:
social and environmental status, personal history of
smoking habit, physical functioning as expressed by the
distance walked in 6-minute (WD) [18], cognitive func-
tion rated by the Mini Mental Status Examination
(MMSE) [19], and mood status assessed by the 15-item
Geriatric Depression Scale (GDS) [20].
All the centres were provided with an identical fully com-
puterized water-sealed Stead-Wells spirometer (Baires Sys-
tem; Biomedin; Padua, Italy) that met the standards of the
American Thoracic Society (ATS) recommendations for
diagnostic spirometry [21]. Pulmonary function tests
included baseline spirometry and post-bronchodilator
reversibility test performed using fenoterol 100 μg,
administered throughout a space chamber. Tests were per-
formed with a standardized technique in all centres and a
quality control process was successfully implemented
[16].
Patients gave their written consent to participate in the
study. The study design was approved by the Ethical Com-
mittee of the Coordinating Centre at the University of Pal-
ermo, Italy, and by the Ethical Committee of each
participating centre.
Sample selection
From the initial sample, we excluded patients with incom-
plete spirometric data (N = 212), and also those who had
missing data for MDA (N = 122) or SGRQ (N = 10). We
further excluded people without bronchial obstruction
(FEV1/FVC ≥ 70%, N = 958) and those whose bronchial
obstruction might be due to asthma (N = 137) on the
basis of a diagnostic algorithm [22]. Thus, the final sam-
ple consisted of 531 patients with bronchial obstruction
attributable to COPD.
Follow-up
Vital status at January 30, 2002 was assessed by contacting
the registry office of the last municipality of residence, this
information was obtained for a total of 449 subjects
(84.5%). Causes of death were obtained from the death
certificates.
Analytic approach
We grouped the participants in three groups using both
SGRQ and MDA. For disease specific measures we used
tertiles of the SGRQ (cut-off values: 2 and 34). For generic
measures we used a MDA based score, defined as a com-
bination of depressed mood (GDS ≥ 5) [20], cognitive
impairment (MMSE < 24 [23]), and WD < 25% of pre-
dicted (all absent: score 0; only one present: score 1; more
than one present: score 2).BMC Pulmonary Medicine 2008, 8:14 http://www.biomedcentral.com/1471-2466/8/14
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The agreement of the different classification methods was
calculated using the kappa statistic. We analyzed the mor-
tality associated with increasing health status impairment
using age- and gender-adjusted Cox regression models.
Preliminary analyses showed that the proportional hazard
assumption did not hold for SGRQ classes, therefore we
decided to model age at death instead of follow-up time.
This manipulation made the proportional hazard
assumption tenable and also made it unnecessary to
include age as a covariate. To evaluate whether any of the
two methods could provide information on mortality risk
regardless of the severity of obstruction we also repeated
the analysis including the forced expiratory volume in the
first second, expressed in percent of predicted (FEV1%), as
a covariate. Finally, we evaluated the individual contribu-
tion to the mortality risk of SGRQ and MDA by analysing
them in the same regression model.
All analyses were performed using SAS V9.0 for Windows
(SAS Inc., Cary NC).
Results
We analyzed data from 449 participants (77.3% men,
mean age 73.2 years – SD 5.4). Table 1 shows the distribu-
tion of demographic characteristics along with pulmonary
function parameters, SGRQ, and individual components
of the MDA across classes identified by SGRQ and MDA.
Average age was similar (about 73 years) in groups
obtained by all classification systems. The proportion of
men was constant across SGRQ classes, while it linearly
decreased as impairment in the MDA increased. Pulmo-
nary function, expressed by the FEV1, worsened with
increasing SGRQ or MDA scores. Cognitive function was
not associated with the SGRQ, while physical perform-
ance and mood status were impaired only in the highest
tertile of SGRQ. The agreement of the two classification
systems was poor (weighted κ: 0.194), with the best con-
cordance (63%) observed in the group people having
MDA score = 0 and being in the first tertile of the SGRQ.
Overall, we observed 144 deaths over an average follow-
up time of 55 months (median: 61 months, SD: 17.0),
with an estimated mortality rate of 6.98/100 person/year
(33.9%). The cumulative probability of dying were
29.6%, 22.8%, and 71.8% in people in the first, second
and third tertile of the SGRQ, respectively, and 33.5%,
40.4%, and 63.8% for MDA scores 0, 1 and 2, respectively.
The relationship between worsening health status, rated
by SGRQ or MDA, and mortality after 18 months of fol-
low up is clearly evident in Figure 1.
Twenty out of the 144 deaths were from pulmonary
causes (13.4%) and the probability of dying for such
causes was 31.3% among those in the upper tertile of the
SGRQ score, but only 12.7% among those having a MDA
score of 2.
Compared to people in the first tertile of SGRQ score,
those in the second tertile had a sex-adjusted HR of 1.22
(0.75 – 1.98) and those in the third tertile of 2.90 (1.92 –
4.40). Adjustment for FEV1, however, caused a decrease in
the estimated association, although having a high SGRQ
score was still associated with a 86% increase in mortality
(95% CI: 1.14 – 3.02). Adjusting for the MDA score,
Table 1: Demographic and clinical characteristics of participants according to disease severity or health status measures.
SGRQ tertile 1 SGRQ tertile 2 SGRQ tertile 3
(N = 149) (N = 147) (N = 153)
Mean age (SD) 73.7 (5.9) 73.1 (4.9) 72.9 (5.4)
Males (%) 75.2 76.9 79.7
Mean FEV1 % (SD) 88.7 (19.7) 75.0 (21.1) 52.0 (20.3)
Mean SGRQ score (SD) 0.1 (0.4) 18.3 (9.4) 54.4 (14.0)
Mean WT % (SD) 73.5 (25.1) 76.8 (23.3) 60.2 (26.0)
Mean MMSE score (SD) 27.7 (2.5) 27.5 (2.6) 25.9 (4.2)
Mean GDS score (SD) 3.0 (3.2) 2.8 (2.7) 4.9 (3.3)
MDA score 0 MDA score 1 MDA score 2
(N = 224) (N = 155) (N = 70)
Mean age (SD) 73.0 (5.2) 73.4 (5.3) 73.6 (6.4)
Males (%) 82.6 74.2 67.1
Mean FEV1 % (SD) 77.4 (25.0) 69.2 (25.2) 59.3 (22.1)
Mean SGRQ score (SD) 16.1 (19.0) 29.8 (24.0) 40.2 (31.1)
Mean WD % (SD) 83.4 (18.8) 64.3 (24.1) 40.1 (17.8)
Mean MMSE score (SD) 28.2 (1.7) 27.0 (2.9) 23.7 (5.2)
Mean GDS score (SD) 1.6 (1.4) 4.9 (3.1) 7.7 (2.7)BMC Pulmonary Medicine 2008, 8:14 http://www.biomedcentral.com/1471-2466/8/14
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instead, did not cause any important change in the hazard
ratio estimates (table 2).
The MDA score also was associated with mortality with a
HR of 1.49 (95% CI: 1.02 – 2.18) for people with score =
1 and 2.01 (95% CI: 1.31 – 3.08) for people with score =
2. Among the individual components of the MDA we
found the strongest association for the WD (HR: 1.84;
95% CI: 1.31 – 2.59), while depression seems to have
lesser importance (HR: 1.55; 95% CI: 1.10 – 2.18) and
cognitive impairment was not associated with overall
mortality (HR: 0.80; 95% CI: 0.49 – 1.29). After adjust-
ment for severity of obstruction, however, the association
between the MDA score and mortality was no more evi-
dent (table 2), and among the individual components of
the score, only the WD was still associated with the out-
come (table 3).
Discussion
This study shows that a disease-specific health status index
and MDA provide different profiles of health status in an
elderly COPD population, and only the disease-specific
index has prognostic implications when severity of
obstruction is taken into account. Since mortality in
COPD is related to both respiratory and non respiratory
predictors [24,25], the lack of association between mor-
tality and the generic health status index seems to be
counterintuitive. Indeed, most (120/144) of the deaths in
our sample were attributed to non-respiratory causes, and
conditions such as chronic renal failure or cardiovascular
diseases carry important prognostic implications in
COPD populations and have a well known disabling
potential which MDA is more likely to capture than SGRQ
[26]. However, while all the components of our MDA
score were expected to individually predict mortality, only
for the 6' WT this association was present after adjustment
for the severity of obstruction, confirming the prognostic
value of 6'WT [25]. Depression and cognitive impairment,
instead, could in part capture the increased risk for mor-
tality linked to the severity of obstruction, but they do not
carry an excess risk of mortality by themselves.
Depression has an obvious impact on quality of life in
COPD patients [27] but, while it is associated with excess
mortality in the general elderly population [28], only in
two studies it has been found to be negatively associated
with survival [12,29] in people with COPD. These data,
however, come from people with severe or exacerbated
Mortality stratified by SGRQ (panel A) and MDA score  (panel B) Figure 1
Mortality stratified by SGRQ (panel A) and MDA 
score (panel B).
Panel A
Panel B
Table 2: Hazard ratios for mortality associated with health status measured by SGRQ (upper panel) and MDA (lower panel).
HR adjusted for age and gender HR adjusted for age, gender and FEV1% HR adjusted for MDA score
SGRQ tertile 1 1 1 1
SGRQ tertile 2 1.22 (0.75 – 1.98) 1.04 (0.63 – 1.70) 1.22 (0.75 – 1.98)
SGRQ tertile 3 2.90 (1.92 – 4.40) 1.86 (1.14 – 3.02) 2.68 (1.74 – 4.12)
HR adjusted for age and gender HR adjusted for age, gender and FEV1% HR adjusted for SGRQ class
MDA score 0 1 1 1
MDA score 1 1.49 (1.02 – 2.18) 1.25 (0.84 – 1.84) 1.14 (0.77 – 1.69)
MDA score 2 2.01 (1.31 – 3.08) 1.43 (0.91 – 2.23) 1.47 (0.94 – 2.29)BMC Pulmonary Medicine 2008, 8:14 http://www.biomedcentral.com/1471-2466/8/14
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COPD, and this can explain the different finding of our
study, in which the association between depression and
mortality is not independent of bronchial obstruction.
Overall cognitive impairment is an important risk factor
for mortality in the general elderly population [30], but in
the COPD population it has been shown that only the
impairment in specific cognitive tasks, namely executive
and praxic, are associated with mortality, but not impair-
ment in the overall cognitive performance or in non-exec-
utive tasks [9,31]. Another factor that may explain the lack
of association between cognitive impairment and mortal-
ity is that very severe COPD, which is frequently compli-
cated by clinically meaningful cognitive dysfunction [32],
was underrepresented in our population. Furthermore, we
studied only patients with a high quality spirometry, auto-
matically excluding thus most of cognitively deteriorated
patients [16,33].
We confirm the association of the SGRQ score with mor-
tality reported by other investigators [12-15], but in a
sample more representative of the general elderly COPD
population. In fact, current knowledge on the prognostic
value of the SGRQ was obtained either in samples exclud-
ing women [13,15] or in samples of COPD patients
recruited in the hospital setting [12,14]. The association
we found, however, was evident only for people in the
upper tertile of this score, indicating a poor discriminative
capacity of this index. Indeed, a bending point in the
decline of the SGRQ is evident only for FEV1 < 50% [34].
Women prevailed in the worst MDA category, while their
prevalence did not distinguish SGRQ tertiles. This finding
suggests that MDA captures health status dimensions
which are more sensible to deterioration in women.
Indeed, it has been demonstrated that in a broad elderly
population disability and depression are more prevalent
and incident among women [35,36]. Furthermore, preva-
lence of depressive symptoms has been reported to be
higher among women than among men with COPD [37].
Finally, non-respiratory factors seem to be related to mor-
tality in women, but non in men, with COPD [38].
Accordingly, MDA classificatory and discriminative prop-
erties are expected to improve for increasing prevalence of
females in the COPD populations. Furthermore, older age
is associated with non respiratory comorbility, and this
might further enhance the classificatory role of MDA
[39,40].
This study has several limitations. First, GOLD 3–4 stages
were underrepresented in our population. Accordingly, a
somewhat different set of MDA components might be
more suited for a more diseased COPD population, while
present conclusions should be considered to apply to the
average ambulatory COPD population. Second, likely due
to the confinement of smoke-related disease to young and
adult women up to now, the female/male ratio (1:3.5) in
our study was lower than that reported (1:2) in the general
population [41]. Third, about 16% of participants were
lost to follow-up and therefore our results may be biased
if reasons for being lost were associated with group mem-
bership. Finally, causes of deaths came from death certifi-
cates, and therefore some misclassification is possible
with regards to pulmonary deaths.
Conclusion
This study shows that in an elderly COPD population a
disease-specific health status measure, the SGRQ, can pre-
dict mortality independently of severity of bronchial
obstruction, although without a clearly linear relation-
ship. On the contrary, the MDA could predict mortality
only when the severity of obstruction was not taken into
account, indicating that its dimensions are affected by the
severity of diseases but are not independently linked to
mortality. Our data support the conclusion that disease-
specific health status measures may be more useful as a
prognostic tool than generic instruments in an elderly
population with mild-moderate COPD.
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